yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34365891-0220EB15-6703-47F3-B334-D22C0219B170
Q34365891-0220EB15-6703-47F3-B334-D22C0219B170
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34365891-0220EB15-6703-47F3-B334-D22C0219B170
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
P2860
Q34365891-0220EB15-6703-47F3-B334-D22C0219B170
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34365891-0220EB15-6703-47F3-B334-D22C0219B170
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d388d040a4a8d8208faf3f15f5489e0333d2324b
P2860
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group